WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Results 1-10 of 1,786 for Criteria: Office(s):all Language:ES Stemming: true maximize
Página anterior 1 2 3 4 5 6 7 8 9 10 Página siguiente
Page: / 179  Go >
RSS icon map icon

Analysis
Analysis

List Length
No translation
NoCtrTitlePubDateInt.ClassAppl.NoApplicantInventor
1. WOWO/2014/161516 - OXA- AND THIA-DIAZOLES USEFUL IN THE TREATMENT OF TUBERCULOSIS09.10.2014
C07D 413/04
PCT/CZ2013/000131UNIVERZITA KARLOVA V PRAZE FARMACEUTICKA FAKULTA V HRADCI KRALOVEHRABALEK, Alexandr
A substituted diazole of genera l formula (1) wherein X is 0 or S; R is selected from the group consisting of: H, NH2-, C1-C11n alkyl, cyclohexyl-, benzyl-, phenyl-, pyridyl- or phenyl- substituted, in positions 2, 3, 4 or 5, by one or more electron-acceptor groups comprising -N02, -N(a lkyl)3, -CF3, CC13, -CN, -COOH, -COOAlk, -COOAr, -CHO, -COAlk, -COAr, -F, -CI, -Br, -I, and/or electron-donor groups comprising -NH2, -N Halkyl, -N(alkyl)2, -OH, -Oalkyl, -Oaryl, -NHCOCH3, -NHCOalkyl; -NHCOaryl; -alkyl, -aryl, wherein when R1 and R3 is -N02, then R2 a R4 is -H, or when R1 and R3 is -H, then R2 and R4 is -N02. These compounds can be prepared by easy synthesis and have low toxicity and significant activity against mycobacteria including their multiresistant strains. The invention provides also a pharmaceutical preparation having substituted diazole of formula (I) as the active ingredient, as well as the use of this substituted diazole as antituberculotic.

2. WOWO/2014/161517 - SKI09.10.2014
A63C 5/02
PCT/CZ2014/000034PETERKA, DušanPETERKA, Dušan
According to the invention, the ski (1) comprises an end part (32) which extends together with the running surface (14) in a straight manner or is curved upwards. The lower side of the front part (8) of the base (6) of an attachment (4) rests on the upper side of the end part (32) of the ski (1). A nose-shaped section (33) extends downwards from said base (6) in the region of the end surface (31) of the end part (29) or in the region of the end surface (31) of the ski end part (29) which is connected to the end of the ski (1), said nose-shaped part resting securely on the adjacent end surface (31). The lower side of the base (6) of the attachment (4) extends on the adjacent lower side of the end part (29) continuously in the region of the nose-shaped part (33), and if the end part (32) of the running surface (14) is straight, it extends from the region of the nose-shaped part (33) in a continuously curved upwards manner counter to the direction of travel of the ski (1). A thin projection (7) extends downwards on each side of the base (6) of the attachment (4). Two guiding projections (34) having an elongate shape are arranged on the lower side (13) of the rear part (12) of the base (6) of the attachment (4) between the sides of the base (6). The heel part (16) of the safety binding (17) is secured to the support surface (21) of the base (6) of the attachment (4) and the front part (20) of the safety binding (17) is applied in front of said latter, on a second surface (22) on the upperside (18) of the ski (1).

3. WOWO/2014/154189 - A METHOD OF PRODUCTION OF POTASSIUM NITRATE BY ELECTRODIALYSIS AND APPARATUS FOR MAKING THE SAME02.10.2014
C01D 9/08
PCT/CZ2014/000030MEMBRAIN S.R.O.MACHUCA, Lubomir
The invention concerns a method of production of potassium nitrate by means of electrodialysis, consisting in the exchange of ions between solution of potassium chloride and solution of ammonium nitrate, nitric acid or sodium nitrate. This exchange of ions occurs in electric field in a system of ion-exchange membranes (see Figure 1), containing at least one sequence of anion-exchange membranes (AM1, AM2) and cation-exchange membranes (CM1, CM2), alternating and creating at least four intermembrane spaces (C1, C2, D1, D2). In these intermembrane spaces on both sides of membranes, solutions of the said chemical compounds flow in the following manner: solution of input potassium chloride flows in the first interaiembrane space (D1) before the first anion-exchange membrane; solution of ammonium nitrate, nitric acid or sodium nitrate flows in the third intermembrane space (D2) between the first cation-exchange membrane (CM1) and the second anion-exchange membrane; while solution of the main product - potassium nitrate - flows in the fourth intermembrane space (C2) between the second anion-exchange membrane (AM2) and the second cation-exchange membrane (CM2), and solution of by-product - ammonium chloride, hydrochloric acid or sodium chloride - flows in the second intermembrane space (C1) between the first anion-exchange membrane (AMI) and the first cation-exchange membrane (CM1). The invention also concerns an apparatus to perform this method.

4. WOWO/2014/154188 - METHOD OF PHASE GRADIENT RADIOGRAPHY AND ARRANGEMENT OF AN IMAGING SYSTEM FOR APPLICATION OF THE METHOD02.10.2014
A61B 6/00
PCT/CZ2013/000045INSTITUTE OF EXPERIMENTAL AND APPLIED PHYSICSJAKŮBEK, Jan
Radiation imaging method including steps of generation of at least one radiation microbeam by a radiation source, radiation penetration through the examined object and its caption by a detector, while the difference between the position of the non- refracted microbeam detected without the examined object and the position of the refracted microbeam detected with the examined object defines refraction angle in a particular point of the examined object expressing the size of local gradient of refractive index corresponding to the phase gradient image (PGI) of the examined object, while the radiation on the way from the source (1) to the detector (7) passes through a directing element (2) which forms and directs radiation microbeam to the boundaries between the pixels (14) of the detector (7) where the incident radiation particles generate an analog signal in the pixels (14) adjacent to the boundary and each of the pixels (14) detects the appropriate part of the signal, after which the difference (8) of the position between the refracted microbeam (5) and the non- refracted microbeam (6) is obtained from the change of the analog signal sharing within the appropriate pixels (14) adjacent to the boundary.

5. WOWO/2014/146622 - VAPOR PERMEABLE FOIL OR LAMINATE WITH ANTIMICROBIAL SURFACE TREATMENT25.09.2014
A01N 25/28
PCT/CZ2014/000029CENTRUM ORGANICKÉ CHEMIE S.R.O.KOŘĺNKOVÁ, Radka
Invention describes vapor permeable foil or laminate with antimicrobial surface treatment. On the surface of foil or laminate is created thin layer with photoactive compound. Photoactive compound is able react with light having wavelength from 400 nanometres to 700 nanometres. Thin layer with photoactive compound is permanently on the surface of foil or laminate.

6. WOWO/2014/139484 - MOBILE FUELLING STATION18.09.2014
B67D 7/78
PCT/CZ2013/000040ŽERDĺK, MiroslavŽERDĺK, Miroslav
A mobile fulling station comprises a frame made of beams that are welded together. The frame is covered by metal sheets (1) and the inner space of the thereby created housing is subdivided in a liquid storage room (7) and a room (6) for the control and service facilities. In order to improve the leak proof of the housing the weld seams of the beams are covered by an addtional L-profile beam (12) such that a small space (13), an additional safety space, is created. The pressure within that space is lower than the ambiant pressure nd monitored by sensors.

7. WOWO/2014/139489 - METHOD FOR THE PREPARATION OF TICAGRELOR AND INTERMEDIATES SUITABLE THEREFORE18.09.2014
C07D 487/04
PCT/CZ2014/000028ZENTIVA K.S.RIHA, Jaroslav
A method for the preparation of ticagrelor of formula I, wherein the key reaction of the entire synthesis is condensation of an amino cyclopentane diol with pyrimidine, providing the isolated intermediate of formula IV. The amino cyclopentane diol is used for the reaction with pyrimidine without any protecting group on the hydroxyls in positions 1 and 2. Using the compound without a protecting group eliminates the necessity of deprotection in the subsequent synthetic steps.

8. WOWO/2014/139486 - REGULATION DEVICE PREVENTING ELECTRICAL SHOCK IN DEVICES USING ELECTROTHERAPY FOR TREATMENT AND THE METHOD OF PREVENTION OF ELECTRIC SHOCK18.09.2014
A61N 1/08
PCT/CZ2014/000025KARES, JiriKARES, Jiri
The regulation device, preventing electrical shock in devices using electrotherapy for treatment, consists of a starting circuit (5) which is connected to the circuit (6) for gradual regulation of output current, which is further connected to an amplifier (8) of regulation deviation, which is interconnected to a stabilizer (7) of output current with a delay element, and a switch (9) of a stand-by and operation mode of the device. To prevent electrical shock in devices using electrotherapy for treatment, the device must meet the following conditions between the time delay Treg of the output current from the regulator block (4), the time Tvyp for quick switching of the device from operation mode to stand-by mode, and the time Trun of gradual regulation of the amplitude set-up of the output current: Treg > Tvyp Treg « Trun A device using electrotherapy for treatment consisting of a power supply block (1), an indication block (2), and a switched-mode power supply block with feedback (3) connected to a regulator block (4) of output current with the delay Treg does not cause electric shock to patients in case of accidental disruption of medical therapy when the device is in operation mode.

9. WOWO/2014/139485 - A METHOD FOR THE PREPARATION OF 5-[(R)-2-(5,6-DIETHYL-INDAN-2-YLAMINO)-L-HYDROXYETHYL]- 8-HYDROXY-(1H)-QUINOLIN-2-ONE (INDACATEROL)18.09.2014
C07D 215/26
PCT/CZ2014/000023ZENTIVA, K.S.MECA, Ludek
The invention relates to a new method of synthesis of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)- 1-hydroxyethyl]-8-hydroxy-(1H)-quinolin-2-one of formula (R)-2, known under the generic name indacaterol, which is used for the treatment of chronic obstructive pulmonary disease (COPD). The method comprises preparation of the racemic intermediate 5-[2-(5,6-diethyl-indan-2-ylamino)-1-hydroxyethyl]-8-benzyloxy-(1H)-quinolin-2-one of formula 1, which is further, in an arbitrary order, chirally resolved and debenzylated, and subsequently indacaterol of formula (R)-2 is isolated.

10. WOWO/2014/139488 - ROTARY TABLE FOR THE DEPOSITION OF THIN SURFACE FILMS ON SUBSTRATES18.09.2014
C23C 14/50
PCT/CZ2014/000027HVM PLASMA, SPOL.S.R.O.DOSTÁL, Jan
The purpose of the present invention is to provide rotary table (1) for deposition of thin surface layers onto substrate (21). Rotary table (1) is adapted for rotating the substrates (21) on three axes (4, 8, 18) of rotation (ω1, ω2, ω3). Resulting surface modification of the substrate (21) is performed over the entire surface with uniform thickness.


Results 1-10 of 1,786 for Criteria: Office(s):all Language:ES Stemming: true
Página anterior 1 2 3 4 5 6 7 8 9 10 Página siguiente